MedTrace Logo

Strategies for Transfusion of Platelets (SToP)

NCT00420914 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2008-05-28

No results posted yet for this study

Summary

To evaluate the hemostatic efficacy of a low dose platelet transfusion strategy compared to a standard dose platelet transfusion strategy.

Conditions

Interventions

PROCEDURE

low dose of 2.25 x 10^11 platelets/transfusion (range 1.5 to 2.9)

Sponsors & Collaborators

  • Dartmouth-Hitchcock Medical Center

    collaborator OTHER

  • Haukeland University Hospital

    collaborator OTHER

  • Ottawa Hospital Research Institute

    collaborator OTHER

  • Cedars-Sinai Medical Center

    collaborator OTHER

  • University Health Network, Toronto

    collaborator OTHER

  • Hamilton Health Sciences Corporation

    lead OTHER

Principal Investigators

  • Nancy M Heddle, MSc., FCSMLS(D) · McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-31

Countries

  • United States
  • Canada
  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00420914 on ClinicalTrials.gov